Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 12
1966 18
1967 25
1968 31
1969 25
1970 39
1971 31
1972 36
1973 52
1974 54
1975 68
1976 49
1977 43
1978 46
1979 67
1980 87
1981 63
1982 83
1983 96
1984 87
1985 100
1986 131
1987 129
1988 122
1989 138
1990 185
1991 148
1992 148
1993 126
1994 167
1995 186
1996 177
1997 179
1998 187
1999 193
2000 175
2001 219
2002 233
2003 311
2004 322
2005 306
2006 338
2007 399
2008 384
2009 368
2010 389
2011 407
2012 407
2013 401
2014 397
2015 368
2016 319
2017 334
2018 312
2019 317
2020 284
2021 144
Text availability
Article attribute
Article type
Publication date

Search Results

9,591 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS. Fong PC, et al. N Engl J Med. 2009 Jul 9;361(2):123-34. doi: 10.1056/NEJMoa0900212. Epub 2009 Jun 24. N Engl J Med. 2009. PMID: 19553641 Free article. Clinical Trial.
Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor.
Herman AE, Chinn LW, Kotwal SG, Murray ER, Zhao R, Florero M, Lin A, Moein A, Wang R, Bremer M, Kokubu S, Serone AP, Hanze EL, Viberg A, Morimoto AM, Winter HR, Katsumoto TR. Herman AE, et al. Clin Pharmacol Ther. 2018 Jun;103(6):1020-1028. doi: 10.1002/cpt.1056. Epub 2018 Mar 23. Clin Pharmacol Ther. 2018. PMID: 29484638 Clinical Trial.
Almitrine bismesylate.
Smith PD, Gotz VP, Ryerson GG. Smith PD, et al. Drug Intell Clin Pharm. 1987 May;21(5):417-21. doi: 10.1177/106002808702100503. Drug Intell Clin Pharm. 1987. PMID: 3556128 Review.
9,591 results